Nyxoah (NYXH) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.402x

Based on the latest financial reports, Nyxoah (NYXH) has a cash flow conversion efficiency ratio of -0.402x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-20.48 Million ≈ $-23.95 Million USD) by net assets (€50.95 Million ≈ $59.57 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Nyxoah worth for the company's overall valuation and market capitalisation.

Nyxoah - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Nyxoah's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Nyxoah Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nyxoah ranked by their cash flow conversion efficiency. See Nyxoah cash debt coverage ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
Gold Terra Resource Corp
V:YGT
-0.011x
Namib Minerals Ordinary Shares
NASDAQ:NAMM
-0.351x
Rorze Systems Corporation
KQ:071280
0.008x
Harboes Bryggeri A/S
CO:HARB-B
0.029x
Abionyx Pharma SA
PA:ABNX
-0.314x
SUI Group Holdings Limited
NASDAQ:SUIG
-0.023x
Maan Aluminium Limited
NSE:MAANALU
0.076x
SLP Resources Bhd
KLSE:7248
0.017x

Annual Cash Flow Conversion Efficiency for Nyxoah (2017–2024)

The table below shows the annual cash flow conversion efficiency of Nyxoah from 2017 to 2024. View NYXH share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €113.25 Million
≈ $132.41 Million
€-49.23 Million
≈ $-57.55 Million
-0.435x +4.85%
2023-12-31 €98.02 Million
≈ $114.60 Million
€-44.78 Million
≈ $-52.35 Million
-0.457x -91.15%
2022-12-31 €120.32 Million
≈ $140.67 Million
€-28.76 Million
≈ $-33.62 Million
-0.239x -40.19%
2021-12-31 €148.62 Million
≈ $173.75 Million
€-25.34 Million
≈ $-29.62 Million
-0.170x -141.38%
2020-12-31 €97.19 Million
≈ $113.63 Million
€-6.86 Million
≈ $-8.02 Million
-0.071x +95.58%
2019-12-31 €3.71 Million
≈ $4.34 Million
€-5.93 Million
≈ $-6.94 Million
-1.598x -105.20%
2018-12-31 €10.45 Million
≈ $12.22 Million
€-8.14 Million
≈ $-9.52 Million
-0.779x +57.47%
2017-12-31 €4.53 Million
≈ $5.29 Million
€-8.29 Million
≈ $-9.69 Million
-1.831x --

About Nyxoah

BR:NYXH Belgium Medical Instruments & Supplies
Market Cap
$68.91 Million
€58.95 Million EUR
Market Cap Rank
#20753 Global
#90 in Belgium
Share Price
€1.37
Change (1 day)
-1.15%
52-Week Range
€1.15 - €5.99
All Time High
€29.90
About

Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company's lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgi… Read more